HONY Capital
弘毅投资
HONY Capital (弘毅投资) is a Chinese private equity firm known for buyout-oriented investments. In a 2022 retrospective, 暗涌Waves cited it as a representative player in China's early buyout wave, alongside cases like Newbridge Capital's takeover of Shenzhen Development Bank . Its president Cao Yonggang (曹永刚) publicly reflected on Charlie Munger's influence after Munger's death in late 2023, describing him as an enduring symbol of calm, wisdom, and clarity in investing . The firm also appeared as a participant in Aikelian Biotechnology's $41 million founding round in August 2025, alongside Sequoia China and others .elsewhere's corpus does not contain a detailed fund profile, team roster, or AUM figure for HONY Capital.
AI-generated — may contain errors, please verify.
Coverage
5Y News｜Aikelian Biotechnology Completes $68.7 Million Funding Round
Aikelian Biotech has successfully completed an oversubscribed $68.7 million funding round.
五源资本·The Day Munger Died: 18 WeChat Moments About Him
Mourning the Passing of a Wise Mind
暗涌Waves·Buyouts in China: A "Boy Who Cried Wolf" Fable
After so many cycles of euphoria and heartbreak, will Chinese buyouts finally deliver a different ending this time?
暗涌Waves·
